Angewandte Chemie International Edition · 2025 · 13 citations · 51 references
Life SciencesImmunologyPharmacologyInflammationInnate ImmunityNanobiotechnologyCell-nanoparticle InteractionsGastrointestinal InflammationInflammatory Bowel DiseaseInnate Immune Signaling PathwaysNanomedicineReactive Oxygen SpeciesBioactivityClathrin-coated VesiclesGut Microbiome DysbiosisGut Microbiota DysbiosisInflammatory Bowel Disease ImmunopathogenesisInflammatory Tissue DamageNanoparticlesReactive Oxygen Species-responsive Nanoparticles
Elevated levels of reactive oxygen species (ROS) and gut microbiota dysbiosis are crucial factors that exacerbate inflammatory bowel disease (IBD). To address this, we successfully synthesized zinc sulfide nanoparticles (ZnS NPs) with a particle size of approximately 500 nm and a maximum g-factor of 0.07, utilizing l-/d-cysteine as chiral ligands. Chirality gives NPs unique bioactivity. These chiral ZnS NPs could enter macrophages through the CD44 and clathrin pathways, which enhanced the ability to scavenge ROS, in turn significantly inhibited the NF-κB and NLRP3 signaling pathways, thereby reducing the secretion of TNF-α, IL-6, and IL-1β, while upregulating IL-10. In vivo experimental data showed that l-ZnS NPs outperformed 5-aminosalicylic acid, significantly improving body weight, reducing the IBD activity index, and attenuating tissue damage. Concurrently, l-ZnS NPs exhibited a marked prophylactic effect. The benchmark studies verified that l-ZnS NPs increased the abundance of the beneficial Lachnospiraceae NK4A136 by 10.55-fold and decreased harmful Enterobacter by 2914.00-fold, thereby reshaping the intestinal microecological balance. Pharmacokinetic and biosafety assessments confirmed the safety of l-ZnS NPs. Our findings indicate that chiral ZnS NPs hold great potential as nanodrugs for the treatment and prevention of IBD, providing an important foundation for the development of IBD therapeutic strategies.
51
Enantiomer-dependent immunological response to chiral nanoparticles
Liguang Xu, Xiuxiu Wang, Weiwei Wang et al. · Nature · 2022 · 613 citations
Calcium-Overload-Mediated Tumor Therapy by Calcium Peroxide Nanoparticles
Meng Zhang, Ruixue Song, Yanyan Liu et al. · Chem · 2019 · 519 citations · Full text
Pharmacy, Cancer Biology, Oncology +14